TY - JOUR
T1 - Development and validation of the Rome IV diagnostic questionnaire for adults
AU - Palsson, Olafur S.
AU - Whitehead, William E.
AU - Van Tilburg, Miranda A.L.
AU - Chang, Lin
AU - Chey, William
AU - Crowell, Michael D.
AU - Keefer, Laurie
AU - Lembo, Anthony J.
AU - Parkman, Henry P.
AU - Rao, Satish S.C.
AU - Sperber, Ami
AU - Spiegel, Brennan
AU - Tack, Jan
AU - Vanner, Stephen
AU - Walker, Lynn S.
AU - Whorwell, Peter
AU - Yang, Yunsheng
N1 - Publisher Copyright:
© 2016 by the AGA Institute.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - The Rome IV Diagnostic Questionnaires were developed to screen for functional gastrointestinal disorders, serve as inclusion criteria in clinical trials, and support epidemiologic surveys. Separate questionnaires were developed for adults, children and adolescents, and infants and toddlers. For the adult questionnaire, we first surveyed 1162 adults without gastrointestinal disorders, and recommended the 90th percentile symptom frequency as the threshold for defining what is abnormal. Diagnostic questions were formulated and verified with clinical experts using a recursive process. The diagnostic sensitivity of the questionnaire was tested in 843 patients from 9 gastroenterology clinics, with a focus on clinical diagnoses of irritable bowel syndrome (IBS), functional constipation (FC), and functional dyspepsia (FD). Sensitivity was 62.7% for IBS, 54.7% for FD, and 32.2% for FC. Specificity, assessed in a population sample of 5931 adults, was 97.1% for IBS, 93.3% for FD, and 93.6% for FC. Excess overlap among IBS, FC, and FD was a major contributor to reduced diagnostic sensitivity, and when overlap of IBS with FC was permitted, sensitivity for FC diagnosis increased to 73.2%. All questions were understandable to at least 90% of individuals, and Rome IV diagnoses were reproducible in three-fourths of patients after 1 month. Validation of the pediatric questionnaires is ongoing.
AB - The Rome IV Diagnostic Questionnaires were developed to screen for functional gastrointestinal disorders, serve as inclusion criteria in clinical trials, and support epidemiologic surveys. Separate questionnaires were developed for adults, children and adolescents, and infants and toddlers. For the adult questionnaire, we first surveyed 1162 adults without gastrointestinal disorders, and recommended the 90th percentile symptom frequency as the threshold for defining what is abnormal. Diagnostic questions were formulated and verified with clinical experts using a recursive process. The diagnostic sensitivity of the questionnaire was tested in 843 patients from 9 gastroenterology clinics, with a focus on clinical diagnoses of irritable bowel syndrome (IBS), functional constipation (FC), and functional dyspepsia (FD). Sensitivity was 62.7% for IBS, 54.7% for FD, and 32.2% for FC. Specificity, assessed in a population sample of 5931 adults, was 97.1% for IBS, 93.3% for FD, and 93.6% for FC. Excess overlap among IBS, FC, and FD was a major contributor to reduced diagnostic sensitivity, and when overlap of IBS with FC was permitted, sensitivity for FC diagnosis increased to 73.2%. All questions were understandable to at least 90% of individuals, and Rome IV diagnoses were reproducible in three-fourths of patients after 1 month. Validation of the pediatric questionnaires is ongoing.
KW - Functional Constipation
KW - Functional Dyspepsia
KW - Functional Gastrointestinal Disorder
KW - Irritable Bowel Syndrome
KW - Sensitivity
KW - Specificity
UR - http://www.scopus.com/inward/record.url?scp=84964749466&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2016.02.014
DO - 10.1053/j.gastro.2016.02.014
M3 - Article
C2 - 27144634
AN - SCOPUS:84964749466
SN - 0016-5085
VL - 150
SP - 1481
EP - 1491
JO - Gastroenterology
JF - Gastroenterology
IS - 6
ER -